Nike Names Pfizer CFO David Denton to Succeed Matthew Friend, Shares Rise 1%

Q: Facing a lawsuit, will Nike pass its billion-dollar tariff refund to consumers or pocket it as a corporate windfall?

It is not yet clear that Nike will pass the refund to consumers, and the available evidence points to that being unresolved rather than promised. Nike has said only that its upcoming fourth-quarter and fiscal 2026 results will benefit from tariff refunds that were not included in prior guidance. That signals the money is expected to help earnings, but it is not a commitment to cut prices or reimburse shoppers. The company has also announced a CFO change, but neither that update nor its recent disclosure included a public plan for how the refund would be used. The legal pressure comes from a proposed class action alleging Nike raised prices to offset roughly $1 billion in tariffs and now could recover those same costs again from the government after the tariffs were invalidated. The complaint argues Nike has made no legally binding commitment to return any tariff-related overcharges to consumers. Nike has declined to comment publicly on the suit. That leaves Nike in a different position from companies that have explicitly pledged to pass refunds through. Costco has said it would return money via lower prices, and shipping groups such as FedEx and UPS have made similar commitments to customers. Nike has not. So, based on what is public now, the refund looks more likely to be treated as a corporate financial benefit unless Nike changes course or a court forces a remedy. But that is still an open legal and business question, not a settled outcome.

1 articles · Updated · CNBC · Jun 23

Nike said CFO Matthew Friend will step down and be replaced by Pfizer finance chief David Denton, with the change taking effect Aug. 17.
Shares rose about 1% after the announcement, which came alongside Nike's note that fourth-quarter and fiscal 2026 results due next Tuesday will include tariff-refund benefits not included in prior guidance.
Denton joins from Pfizer, where he currently serves as CFO, giving Nike a new finance leader just ahead of its annual results release.
The timing puts the leadership change at the center of investor focus as Nike prepares to report earnings with an added boost from those refunds.